Satish K Chitneni

6PUBLICATIONS
9CO-AUTHORS
Toxicology (incl. clinical toxicology)Instruments and techniquesBiomolecular modelling and designMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 20, 2026
Radiochemistry and comparative in vitro assessment of PSMA-617 labeled with lead-212 (212Pb), actinium-225 (225Ac), and lutetium-177 (177Lu).

|Jun 25, 2025
Synthesis of DOTA-Based 43Sc Radiopharmaceuticals Using Cyclotron-Produced 43Sc as Exemplified by [43Sc]Sc-PSMA-617 for PSMA PET Imaging.

Jason P Meier, Mohammed Bhuiyan, Richard Freifelder

|Sep 15, 2021
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation.

Zhengyuan Zhou, Michael R Zalutsky, Satish K Chitneni

|Apr 30, 2021
Feasibility of Developing Radiotracers for MDM2: Synthesis and Preliminary Evaluation of an 18F-Labeled Analogue of the MDM2 Inhibitor SP-141.

Satish K Chitneni, Zhengyuan Zhou, Brian E Watts

|Nov 02, 2019
Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab.

Satish K Chitneni, Eftychia Koumarianou, Ganesan Vaidyanathan

|Apr 29, 2018
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.

Patrick C Gedeon, Teilo H Schaller, Satish K Chitneni

Pageof 1

Frequent Collaborators

1 joint publications

Patrick C Gedeon

1 joint publications

Eftychia Koumarianou

1 joint publications

Brian E Watts

1 joint publications

Jason P Meier